Phathom Pharmaceuticals Announces Commercial Availability

VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available at major retail pharmacies and through BlinkRx....

Related Keywords

Canada ,Japan ,United States ,America ,Canadian ,Colin Howden ,Mark Fendrick ,Diarrheacausedbyaninfection Clostridioidesdifficile ,Neurogastroenterol Motil ,Martin Gilligan ,Nick Benedetto ,Eric Sciorilli ,Phathom Pharmaceuticals ,Company Annual Report On Form ,Phathom Pharmaceuticals Inc ,Exchange Commission ,Us Census Bureau ,Drug Administration ,University Of Tennessee College Medicine ,Twitter ,Nasdaq ,Company On Linkedin ,Erosive Esophagitis ,Chief Commercial Officer ,Professor Emeritus ,Tennessee College ,Erosive Acid Reflux ,Erosive Acid ,Human Immunodeficiency Virus ,Patient Informationand ,Prescribing Informationfor ,Patient Information ,Annual Report ,Private Securities Litigation Reform Act ,Verses Lansoprazole ,Gastroesophageal Reflux ,World Population ,Accessed May ,Nasdaq Phat ,Vonoprazan ,Voquezna ,Gastrointestinal Disease ,Herd ,Biotech ,Fda Approval ,Pharmaceuticals ,R Amp D ,